Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955984847> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2955984847 endingPage "4843" @default.
- W2955984847 startingPage "4843" @default.
- W2955984847 abstract "Abstract An emerging body of literature suggests a role of TP53 pathway in antitumor immunity including antigen presentation and T cell proliferation. Stabilization of TP53 could therefore alter the immune tumor microenvironment, enabling the immune system to target tumor cells more effectively. APR-246 covalently modifies the core domain of cellular TP53 through the alkylation of thiol groups, leading to reactivation of endogenous TP53 activity. To further study the effect of APR-246 on antitumor immunity we used a B16 pre-clinical melanoma mouse model. In vitro treatment of B16 cells with APR-246 caused intracellular accumulation of TP53, leading to increased apoptosis. However, treatment of B16-melanoma bearing mice with APR-246 monotherapy did not result in a statistically significant change in tumor growth or survival. Analyses of the tumor immune microenvironment showed increased immune potentiating M1 polarized tumor-associated macrophages, and Granzyme B activity in CD8+ T cells, suggesting enhanced anti-tumor immunity. Concomitantly, there was increased PD-L1 expression in the macrophages, PD-1 expression on CD8+ T cells, and Foxp3+ Tregs in tumors from APR-246 treated animals. Therefore, we decided to combine anti-PD-1 antibody (RMP-1) to APR-246 treatment in tumor-bearing mice. The combination led to a significant delay in tumor growth (P < 0.001) and improved survival of B16-bearing mice compared to anti-PD1 or APR-246 monotherapies (P < 0.01). Improved responses were also seen in MC38 colorectal cancer-bearing mice (P < 0.01). The anti-tumor effects of APR-246 and anti-PD1 were T cell dependent and abrogated in hosts lacking T cells. Analyses of the tumor immune microenvironment showed that the combination decreases proliferation but increases cytolytic activity of CD8+ T cells compared to anti-PD1 alone. We next studied the effect of combining APR-246 with anti-PD1+ anti-CTLA-4 (9B9). Combination of APR-246 with dual immune checkpoint blockade using anti-PD1 and anti-CTLA-4 showed further tumor growth inhibition in B16-melanoma compared to monotherapies (P < 0.001). Our studies support a role for restoring TP53 in the tumor microenvironment and provide evidence that reactivation of TP53 by APR-246 can enhance anti-tumor immune responses and inhibit tumor growth in preclinical models. Citation Format: Arnab Ghosh, Judith Michel, Lauren Dong, Nathan Suek, Hong Zhong, Sadna Budhu, Olivier de Henau, Jedd Wolchok, Taha Merghoub. TP53-stabilization with APR-246 enhances antitumor effects of immune checkpoint blockade in preclinical models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4843." @default.
- W2955984847 created "2019-07-12" @default.
- W2955984847 creator A5002951130 @default.
- W2955984847 creator A5036493414 @default.
- W2955984847 creator A5045239138 @default.
- W2955984847 creator A5054656505 @default.
- W2955984847 creator A5060497159 @default.
- W2955984847 creator A5062466068 @default.
- W2955984847 creator A5082626339 @default.
- W2955984847 creator A5083615866 @default.
- W2955984847 creator A5084183387 @default.
- W2955984847 date "2019-07-01" @default.
- W2955984847 modified "2023-10-18" @default.
- W2955984847 title "Abstract 4843: TP53-stabilization with APR-246 enhances antitumor effects of immune checkpoint blockade in preclinical models" @default.
- W2955984847 doi "https://doi.org/10.1158/1538-7445.am2019-4843" @default.
- W2955984847 hasPublicationYear "2019" @default.
- W2955984847 type Work @default.
- W2955984847 sameAs 2955984847 @default.
- W2955984847 citedByCount "3" @default.
- W2955984847 countsByYear W29559848472021 @default.
- W2955984847 countsByYear W29559848472022 @default.
- W2955984847 crossrefType "journal-article" @default.
- W2955984847 hasAuthorship W2955984847A5002951130 @default.
- W2955984847 hasAuthorship W2955984847A5036493414 @default.
- W2955984847 hasAuthorship W2955984847A5045239138 @default.
- W2955984847 hasAuthorship W2955984847A5054656505 @default.
- W2955984847 hasAuthorship W2955984847A5060497159 @default.
- W2955984847 hasAuthorship W2955984847A5062466068 @default.
- W2955984847 hasAuthorship W2955984847A5082626339 @default.
- W2955984847 hasAuthorship W2955984847A5083615866 @default.
- W2955984847 hasAuthorship W2955984847A5084183387 @default.
- W2955984847 hasConcept C167672396 @default.
- W2955984847 hasConcept C190283241 @default.
- W2955984847 hasConcept C203014093 @default.
- W2955984847 hasConcept C2776107976 @default.
- W2955984847 hasConcept C2777658100 @default.
- W2955984847 hasConcept C2777701055 @default.
- W2955984847 hasConcept C2779341262 @default.
- W2955984847 hasConcept C2779727006 @default.
- W2955984847 hasConcept C2780380082 @default.
- W2955984847 hasConcept C2780851360 @default.
- W2955984847 hasConcept C502942594 @default.
- W2955984847 hasConcept C55493867 @default.
- W2955984847 hasConcept C71924100 @default.
- W2955984847 hasConcept C86803240 @default.
- W2955984847 hasConcept C8891405 @default.
- W2955984847 hasConceptScore W2955984847C167672396 @default.
- W2955984847 hasConceptScore W2955984847C190283241 @default.
- W2955984847 hasConceptScore W2955984847C203014093 @default.
- W2955984847 hasConceptScore W2955984847C2776107976 @default.
- W2955984847 hasConceptScore W2955984847C2777658100 @default.
- W2955984847 hasConceptScore W2955984847C2777701055 @default.
- W2955984847 hasConceptScore W2955984847C2779341262 @default.
- W2955984847 hasConceptScore W2955984847C2779727006 @default.
- W2955984847 hasConceptScore W2955984847C2780380082 @default.
- W2955984847 hasConceptScore W2955984847C2780851360 @default.
- W2955984847 hasConceptScore W2955984847C502942594 @default.
- W2955984847 hasConceptScore W2955984847C55493867 @default.
- W2955984847 hasConceptScore W2955984847C71924100 @default.
- W2955984847 hasConceptScore W2955984847C86803240 @default.
- W2955984847 hasConceptScore W2955984847C8891405 @default.
- W2955984847 hasIssue "13_Supplement" @default.
- W2955984847 hasLocation W29559848471 @default.
- W2955984847 hasOpenAccess W2955984847 @default.
- W2955984847 hasPrimaryLocation W29559848471 @default.
- W2955984847 hasRelatedWork W2913282972 @default.
- W2955984847 hasRelatedWork W3029687374 @default.
- W2955984847 hasRelatedWork W3153709335 @default.
- W2955984847 hasRelatedWork W3158438576 @default.
- W2955984847 hasRelatedWork W3177607563 @default.
- W2955984847 hasRelatedWork W3217412908 @default.
- W2955984847 hasRelatedWork W4224222365 @default.
- W2955984847 hasRelatedWork W4285731353 @default.
- W2955984847 hasRelatedWork W4291378227 @default.
- W2955984847 hasRelatedWork W4304979265 @default.
- W2955984847 hasVolume "79" @default.
- W2955984847 isParatext "false" @default.
- W2955984847 isRetracted "false" @default.
- W2955984847 magId "2955984847" @default.
- W2955984847 workType "article" @default.